NCT05061823 2026-02-02Bintrafusp Alfa Program Rollover StudyEMD SeronoPhase 3 Completed22 enrolled 11 charts
NCT02723955 2024-12-27Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)GlaxoSmithKlinePhase 1 Completed829 enrolled 100 charts